ALB and cancer: PNI, calculated from serum albumin levels and lymphocyte counts, is a well-established indicator for assessing nutritional and immune status and predicting risk in malignant tumors, which has been extensively used to evaluate various solid tumors’ treatment outcomes (28–30).